Research Society for the Study of Diabetes in India (RSSDI), the largest organization of diabetes health care professionals and researchers in Asia has endorsed FIT (Forum for Injection Technique) India recommendations for best practice in insulin injection technique for people living with diabetes through its 6444 life members from 29 Indian States and Union Territories. The initiative is expected to benefit over 2 million diabetes patients with regards to long time insulin and insulin-like therapy adherence, smooth drug delivery and minimisation of adverse side effects.
In the past, several studies have cited reasons as to why some patients dread insulin injection usage. According to a study published in Diabet Med, 20 percent of insulin users often or sometimes skipped their injections while 10% restricted their number of daily injections due to needle anxiety, pain or embarrassment. Another study has found that bacterial contamination, local inflammatory changes and injection pain increased in direct proportion to needle re-use, highlighting an increased risk of infection.
Prof S V Madhu, professor and head, Dept. of Medicine & Endocrinology, UCMS-GTB Hospital & President, Research Society for Study of Diabetes in India (RSSDI) said, "The number of people with Type 2 diabetes is on the rise in every country, with earlier diagnosis and longer life spans meaning that there is an increasing likelihood that they will need to use injectable therapies to control their condition. Therefore it becomes extremely important that standard insulin techniques and best practices are adopted across the country at par with global standards."
FIT India is an autonomous organisation which supports people with diabetes using injectable therapies to achieve the best possible health outcomes that can be influenced by correct injection technique. The development of FIT and the subsequent India recommendations for injection technique have been supported by prominent medical technology firm Becton, Dickinson & Co. (BD India).
Dr Rajeev Chawla, senior consultant Diabetologist and Secy, Research Society for Study of Diabetes in India (RSSDI) said, "Poor technique, including the use of an inappropriate needle length, failure to rotate injection sites and the re-use of needles, can lead to insulin being absorbed in an unpredictable manner, potentially leading to complications such as hypoglycaemia, hyperglycaemia and even ketoacidosis in patients with Type 1 diabetes. Injection technique addresses all these factors, and more."
As per the FIT recommendations, special emphasis is to be given to counter complications arising out of incorrect usage of injections and usage in special groups like elderly population, pregnant women and people with weak immunity. The recommendations also suggest correct injection technique that can help protect against lipohypertrophy (lump formation), unexplained hypoglycemia (low blood sugar) and blood glucose variation.